Viridian LLC 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-12 8:45 pm Unchanged |
2024-03-21 | 13D | Dianthus Therapeutics, Inc. DNTH |
Viridian LLC | 1,090,283 3.720% |
0 (Unchanged) |
Filing |
| 2023-09-21 4:34 pm Purchase |
2023-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH |
Viridian LLC | 1,090,283 7.400% |
1,090,283 (New Position) |
Filing |